ONCOPHARM CORP has a total of 20 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are INST FOR PHARM DISCOVERY INC, SELVI & C SPA and VITA INVEST SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Czechia | 1 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Poland | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Robin Jean-Pierre | 18 |
#2 | Dhal Robert | 13 |
#3 | Radosevic Nina | 11 |
#4 | Marie Jean-Pierre | 11 |
#5 | Robin Julie | 10 |
#6 | Blanchard Julie | 8 |
#7 | Charbonnel Sandra | 6 |
#8 | Chauviat Ludovic | 6 |
#9 | Cavoleau Sylvie | 6 |
#10 | Mevelec Laurence | 5 |
Publication | Filing date | Title |
---|---|---|
AU2002304338A1 | Highly purified and crystalline form of harringtonine | |
CA2440391A1 | Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives | |
AU7940500A | New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents | |
IL138563D0 | Novel cephalotaxane derivatives and process for their preparation | |
CZ20003451A3 | Novel cephalotaxane derivatives and process of their preparation |